Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pessary Market Outlook (2022 to 2032)

A newly released Pessary Market analysis report by Future Market Insights shows that global sales of the Pessary Market in 2021 were held at US$ 289.8 Million. With a CAGR of 10.2%, the market is projected to reach a valuation of US$ 831.3 Million by 2032. Ring Pessary is expected to be the highest revenue-generating category, projected to register a CAGR of 11.2% from 2022 to 2032.

Attributes Details
Global Pessary Market Size (2022) US$ 316 Million
Global Pessary Market Size (2032) US$ 831.3 Million
Global Pessary Market CAGR (2022 to 2032) 10.2%
USA Pessary Market CAGR (2022 to 2032) 11.1%
Key Companies Covered
  • MedGyn Products, Inc.
  • Cooper Surgical Inc.
  • Personal Medical Corp.
  • Panpac Medical Corp
  • Smiths Medical
  • Thomas Medical
  • Artisan Medical
  • Bioteque America, Inc.
  • Integra LifeSciences Corporation
  • Dr. Arabin GmbH & Co.
  • Medgyn Products, Inc.
  • Wallach Surgical Devices

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Pessary Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Pessary Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pessary Market increased at around 8.5% CAGR.

The aging population, together with pessaries' high success rate, has been driving the growth of the pessary market. Furthermore, lifestyle-related diseases are becoming more prevalent. The growing prevalence of diseases like pelvic organ prolapse and urinary incontinence will drive the pessary market. Furthermore, growing global awareness of the importance of pessaries during pelvic organ prolapse complications will serve as a growth driver.

For women with POP who want nonsurgical management, a future pregnancy, early-stage prolapse, or are too frail for surgery, pessaries are typically recommended as a first-line treatment option. Patients whose stress incontinence is aggravated by strenuous physical activity may benefit from pessaries. Pessaries provide an opportunity to simulate postsurgical conditions and help patients' expectations regarding symptom reduction in women who present with pelvic pain, back pain, and pressure thought to be caused by POP operations.

Several studies on the success rate of pessary fitting have been conducted, with results ranging from 41% to 74%. Success rates as high as 62 percent have been observed in patients with stage III and IV prolapse, suggesting that pessaries are an excellent option for all populations with severe POP. In the United States, approximately 200,000 POP operations are performed each year. Although not life-threatening, POP could have a major impact on women's standard of living.

What Factors are Propelling the Pessary Demand?

The Fourth International Consultation on Incontinence recommends pessaries, pelvic floor muscle training, and lifestyle counseling as conservative management options for women with Pelvic Organ Prolapse. Vaginal vault prolapse, or some other type of pelvic organ prolapse, affects approximately half of the women aged 50 to 80 years. Childbirth, age, fatness, gastrointestinal issues, or a hysterectomy can all cause uterine prolapse and increase the demand for pessaries.

Because they provide simple, affordable, and safe solutions, vaginal pessaries are a popular treatment option for organ prolapse and incontinence. These factors contribute to the higher patient satisfaction rate in comparison to an alternate solution. As a result, pessaries are now preferred as first-line treatment for POP or stress urinary incontinence.

Among the key factors expected to drive the market during the forecast period are frequent product introductions, a strong emphasis on Research and Development by market players and universities, geographical expansion by key players, and a number of government initiatives. The United Kingdom Clinical Guideline for Proper Procedure in the Use of Vaginal Pessaries for POP is a document prepared by medical professionals and supporters of prolapse pessaries. The goal of the Guideline is to provide multidisciplinary healthcare professionals with guidance and information on best practices in pessary use for prolapse.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How the emergence of Modern Pessaries pulled the growth trigger in Pessary Market?

Pessaries are now made of non-reactive silicone and come in a variety of designs and sizes to accommodate everyone. Silicon has low surface tension and remarkable chemical stability, allowing for biocompatibility and bio-durability in many long-term implant applications, making it suitable for medical applications.

Pessaries can be used as a stopgap measure for women who want to stop having children or are waiting for surgery. It can also be used as a long-term solution for women who do not qualify for surgery.

In June 2021, using artificial intelligence-driven machine learning and 3D design, Femtherapeutics Inc. developed a device to relieve urinary incontinence and discomfort in women suffering from pelvic organ prolapse. Unlike traditional pessaries, which can cause irritation and penetrate soft tissues, resulting in bleeding, the custom-made pessary is intended to support displaced vaginal tissues caused by the condition.

Region-wise Analysis

Which Region is projected to Offer the Largest Opportunity for Pessary Market?

Asia Pacific is the most lucrative region with double-digit projected growth. The fastest rate of expansion in the regional finance industry is predicted to result from younger, expanding populations and a growing focus on wellness.

As the elderly are more prone to incontinence and prolapsed organ disorders (POP), there is a sizable market in this region, with Japan, China, and India being the primary suppliers. Medical tourism is also a key driver behind the market's growth here.

In developing countries, the extent and effects of morbidity associated with pelvic organ prolapse are rarely acknowledged due to patient embarrassment. However, research funded by the United Nations Population Fund (UNFPA) in Nepal has begun to identify the suffering of women from this disorder. UNFPA is assisting in the identification of women with pelvic organ prolapse through reproductive health camps and the hiring of gynecologists to treat these women at district hospitals.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

USA Pessary Market Analysis

The USA is expected to have the largest market of US$ 323.2 Million by the end of 2032 with North America being the dominant player and accounting for over 35% of total sales. With the elderly population in the United States increasing, there is renewed interest in pessaries as a less invasive alternative to surgical repair for pelvic organ prolapse (POP).

They are an excellent choice for women who have not finished having children, do not want surgery, or are ineligible for surgery. Patients suffering from POP and stress urinary incontinence may benefit from long-term pessary use. Although serious side effects are uncommon, many patients find it difficult to insert and remove most pessary types. The design of pessaries should continue to improve, making their use more appealing.

Women in the USA have an 11% lifetime risk of having prolapse or incontinence surgery by the age of 80, with a 30% chance of reoperation after four years. The number of women over the age of 65 in the USA is expected to more than double to reach more than 40 million by 2030, according to the USA Census Bureau.

As the United States population ages, there is renewed interest in the use of pessaries. According to a survey conducted by the American Urogynaecology Society, 77% of those polled used pessaries as their first-line POP therapy. The pessary is still a viable treatment option for prolapse and incontinence.

United Kingdom Pessary Market Analysis

The market in the United Kingdom is expected to gross US$ 42 Million by 2032. The market in the country is expected to witness a CAGR of 12.1% during the forecast period, registering an absolute dollar opportunity of US$ 28.2 Million.

Japan Pessary Market Analysis

In Japan, the market is expected to reach a valuation of US$ 30 Million by 2032. With an absolute dollar opportunity of US$ 20.7 Million during the forecast period, the market is expected to register a CAGR of 12.7%.

South Korea Pessary Market Analysis

The market in South Korea is expected to gross an absolute dollar opportunity of US$ 9.9 Million by 2032. Growing at a CAGR of 10.8% from 2022 to 2032, the market is likely to reach a valuation of US$ 15.5 Million.

Category-wise Insights

Which Pessary Segment is projected to Witness Most Opportunity?

The Ring Pessary segment is forecasted to grow at the highest CAGR of over 11% from 2022 to 2032. Because of their ease of insertion and removal, ring pessaries are typically the first-line pessary for clinicians. They can be used at any stage of POP, but the first and second stages are the most common. The catheter is unfolded once above the pubic symphysis after being inserted into the vagina. The pessary is gently pulled and folded in half to be removed. To help with insertion and removal, a string can be attached to the ring. Patients can easily learn how to do this on their own.

A new disposable, non-invasive vaginal ring pessary is used at home to treat a variety of pelvic floor disorders. The ConTIPI Medical ProVate, for example, is made of a flexible skeleton covered by a soft elastomer and is designed to expand in the vagina, separating the lateral vaginal walls and mechanically preventing cervical and vault descent as well as blocking further descent of the anterior and posterior walls within the rings hollow.

Which Product Type of Pessary is expected to Score the Highest Growth in the Coming Years?

The Hospitals segment is forecasted to grow at the highest CAGR of over 11.4% from 2022 to 2032. With 45% of the total revenue, the hospital segment dominated the vaginal pessary market. This could be attributed to the rising market demand for pessaries among post-operative and hospitalized indwellings. Among factors contributing to the segment's growth is the heightened interest in the notion of organ prolapse, urinary incontinence, and the inclusion of pessaries in private insurance policies. Surgeons are increasingly favoring minimally invasive procedures that will limit post-operation complications and increase recovery times.

Competitive Analysis

Among the leading players in the global Pessary market are Integra Lifesciences, Panpac Medical Corporation, Personal Medical Corporation, Dr. Arabin GmbH & Co., and Wallach Surgical Devices. To gain a competitive advantage in the industry, these market players are investing in product launches, partnerships, mergers and acquisitions, and expansions.

Some of the recent developments in the pessary market are mentioned below:

  • In February 2022, CooperCompanies agreed to purchase Cook Medical's Reproductive Health division, which manufactures noninvasive fertility, obstetrics, and gynecology devices. Cooper will pay US$ 875 million in total, with US$ 675 million paid at closing and the remaining US$ 200 million paid in four US$ 50 million annual installments.
  • In February 2022, Theramex, a global pharmaceutical company specializing in women's health expanded its initial collaboration with Endoceutics to commercialize Intrarosa in Australia. Intrarosa is the first and only DHEA treatment that has been approved for postmenopausal women suffering from moderate to severe vulvovaginal atrophy.
  • In August 2021, Liv Labs developed a reusable female comfort pessary that does not require a doctor's prescription. Patients suffering from incontinence are currently fitted for pessaries, which must be worn for six months before being removed.

The Liv Labs pessary is soft, smooth, and squishy, making insertion and removal easier. It is made of medical-grade silicone. Women can use it whenever they want, whether it is all day or just for a quick trip to the gym.

Similarly, the team at Future Market Insights, which is available in the full report, has tracked recent developments related to companies in the Pessary market

Market Segments Covered in Pessary Market Analysis

By Type:

  • Gellhorn
  • Ring
  • Donut
  • Other Types

By End-Use:

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

How much is the current worth of the Pessary Market?

The global market is worth more than US$ 289.8 Million at present.

What is the sales forecast for Pessary Market?

The value of the Pessary Market is projected to increase at a CAGR of around 10.2% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of the Pessary Market increased at a CAGR of around 8.5% from 2017 to 2021.

What is a key trend shaping the growth of the Pessary Market?

The increasing incidence of pelvic organ prolapse (POP), and urinary incontinence amongst the majority of women, stand as the key trend in the Pessary market.

At what percentage is sales of Pessary Market going to register growth in USA?

The pessary Market in the USA is projected to expand at a CAGR of around 11.1% from 2022 to 2032.

Table of Content

1. Executive Summary | Pessary Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Investment Feasibility Matrix

    3.4. PESTLE and Porter’s Analysis

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032

        5.3.1. Gellhorn

        5.3.2. Ring

        5.3.3. Donut

        5.3.4. Other Types

    5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        6.3.1. Hospitals

        6.3.2. Ambulatory Surgical Centres

        6.3.3. Clinics

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. Middle East and Africa(MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Rest of Latin America

        9.2.2. By Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. United Kingdom

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By End User

    10.4. Key Takeaways

11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

        11.2.2. By Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Thailand

            12.2.1.3. Malaysia

            12.2.1.4. Indonesia

            12.2.1.5. Rest of South Asia

        12.2.2. By Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Type

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By End User

    13.4. Key Takeaways

14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Rest of Middle East and Africa(MEA)

        14.2.2. By Type

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Type

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Type

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Type

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Type

            15.4.2.2. By End User

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Type

            15.5.2.2. By End User

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Type

            15.6.2.2. By End User

    15.7. Italy

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Type

            15.7.2.2. By End User

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Type

            15.8.2.2. By End User

    15.9. United Kingdom

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Type

            15.9.2.2. By End User

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Type

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Type

            15.11.2.2. By End User

    15.12. BENELUX

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Type

            15.12.2.2. By End User

    15.13. China

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Type

            15.13.2.2. By End User

    15.14. Japan

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Type

            15.14.2.2. By End User

    15.15. South Korea

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Type

            15.15.2.2. By End User

    15.16. India

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Type

            15.16.2.2. By End User

    15.17. Thailand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Type

            15.17.2.2. By End User

    15.18. Malaysia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Type

            15.18.2.2. By End User

    15.19. Indonesia

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Type

            15.19.2.2. By End User

    15.20. Australia

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Type

            15.20.2.2. By End User

    15.21. New Zealand

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Type

            15.21.2.2. By End User

    15.22. GCC Countries

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Type

            15.22.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. MedGyn Products, Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Cooper Surgical Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Personal Medical Corp.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Panpac Medical Corp

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Smiths Medical

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Thomas Medical

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Artisan Medical

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Bioteque America, Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Integra LifeSciences Corporation

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Dr. Arabin GmbH & Co.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. Medgyn Products, Inc.

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. Wallach Surgical Devices

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Ureterorenoscopes Market

Published : September 2022

Healthcare

Pharmacy Refrigerators Market

Published : July 2022

Explore Healthcare Insights

View Reports